Lawmakers came together to fund the government on Friday, keeping the lights on in Washington until early next year and ...

When applied to colorectal cancer cells, they demonstrated through molecular and animal experiments ... KIST introduces ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed” or the "Company”), a molecular genetics diagnostic company specializing in ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...

Prichard Colón is a boxer whose life changed for the worse back in 2015. Back then, he was an undefeated boxer with a bright future. Now, he is battling to fully recover from a left-sided ...

Bowel cancer, also known as colorectal cancer, is an aggressive cancer with a high incidence in developed countries.

Kseniya Ovchinnikova/Getty Images A new study found higher levels of inflammation in colorectal cancer tumors, suppressing the body’s ability to fight the disease. Researchers note the typical ...